Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases

Abstract

Brain metastases have a significantly higher proportion of mature vasculature, suggesting that they may be refractory to anti-VEGF therapy. These findings may have implications for clinical trials and biomarker studies evaluating anti-angiogenic agents in brain metastases.